Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Hugo measured Gene Rank description expected final
Results: HTML CSV LaTeX
Showing element 451 to 500 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANAPC10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.078258\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2384\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANAPHASE-PROMOTING COMPLEX SUBUNIT 10; ANAPHASE-PROMOTING COMPLEX 10. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.356213\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.219694396\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANAPC11\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.170664\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2145\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANAPHASE PROMOTING COMPLEX SUBUNIT 11 (HEPATOCELLULAR CARCINOMA ASSOCIATED RING FINGER PROTEIN) (HSPC214). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.749796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.227613911\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANAPC2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.171257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2437\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANAPHASE-PROMOTING COMPLEX SUBUNIT 2; ANAPHASE-PROMOTING COMPLEX 2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.788327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.217241069\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANK2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.038359\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ANKYRIN 2 (BRAIN ANKYRIN) (ANKYRIN B) (ANKYRIN, NONERYTHROID). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.163741\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.234266311\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANK3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0299967\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANKYRIN 3 (ANK-3) (ANKYRIN G). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.128045\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.234266859\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANKRA2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.15014\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANKYRIN-REPEAT FAMILY A PROTEIN 2 (RFXANK-LIKE 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.573028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.262011629\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANKS1B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.310118\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
E2A-PBX1-ASSOCIATED PROTEIN; PUTATIVE 47 KDA PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.652691\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.475137546\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANKS6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0420495\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.174141808\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANLN\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0289077\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3202\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ANILLIN, ACTIN BINDING PROTEIN (SCRAPS HOMOLOG, DROSOPHILA); ANILLIN (DROSOPHILA SCRAPS HOMOLOG), ACTIN BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20992\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.023892241\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANXA11\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.114013\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1048\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANNEXIN A11 (ANNEXIN XI) (CALCYCLIN-ASSOCIATED ANNEXIN 50) (CAP-50) (56 KDA AUTOANTIGEN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.451047\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.252774101\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ANXA7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.149169\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1052\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ANNEXIN A7 (ANNEXIN VII) (SYNEXIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.590289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.252705031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AOF2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.220284\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
706\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.830799\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.265147166\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1B1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.313086\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1164\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 1 BETA 1 SUBUNIT (BETA-ADAPTIN 1) (ADAPTOR PROTEIN COMPLEX AP-1 BETA-1 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN BETA SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 1 BETA LARGE CHAIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25482\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.249506702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1G1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.230865\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1162\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 1 GAMMA 1 SUBUNIT (GAMMA-ADAPTIN) (ADAPTOR PROTEIN COMPLEX AP-1 GAMMA-1 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN GAMMA-1 SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 1 GAMMA-1 LARGE CHAIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.925078\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.24956274\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1M1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.168157\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU 1 SUBUNIT (MU-ADAPTIN 1) (ADAPTOR PROTEIN COMPLEX AP-1 MU-1 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN MU-1 SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN ASSEMBLY PROTEIN COMPLEX 1 MEDIUM CHAIN 1) (CLATHRIN COAT ASSEMBLY PROTEIN A"\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.668251\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.251637484\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.138969\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU 2 SUBUNIT (MU-ADAPTIN 2) (ADAPTOR PROTEIN COMPLEX AP-1 MU-2 SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN MU-2 SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN ASSEMBLY PROTEIN COMPLEX 1 MEDIUM CHAIN 2) (AP-MU CHAIN FAMILY MEMBER MU1B)."\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.552694\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.251439314\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1S1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.113931\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1163\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 1 SIGMA 1A SUBUNIT (SIGMA-ADAPTIN 1A) (ADAPTOR PROTEIN COMPLEX AP-1 SIGMA-1A SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN SIGMA-1A SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 1 SIGMA- 1A SMALL CHAIN) (CLATHRIN COAT ASSEMBLY PROT\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.456524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.249561907\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP1S3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0558748\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1159\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 1 SIGMA 1C SUBUNIT (SIGMA-ADAPTIN 1C) (ADAPTOR PROTEIN COMPLEX AP-1 SIGMA-1C SUBUNIT) (GOLGI ADAPTOR HA1/AP1 ADAPTIN SIGMA-1C SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 1 SIGMA- 1C SMALL CHAIN) (SIGMA 1C SUBUNIT OF AP-1 CL\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.249563625\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP2B1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.29348\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1158\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 2 BETA 1 SUBUNIT (BETA-ADAPTIN) (PLASMA MEMBRANE ADAPTOR HA2/AP2 ADAPTIN BETA SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 2 BETA LARGE CHAIN) (AP105B). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17572\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.249617256\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP2M1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.268272\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2912\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CLATHRIN COAT ASSEMBLY PROTEIN AP50 (CLATHRIN COAT ASSOCIATED PROTEIN AP50) (PLASMA MEMBRANE ADAPTOR AP-2 50 KDA PROTEIN) (HA2 50 KDA SUBUNIT) (CLATHRIN ASSEMBLY PROTEIN COMPLEX 2 MEDIUM CHAIN) (AP-2 MU 2 CHAIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.54054\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.174141535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP3B1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0416917\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2882\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 3 BETA 1 SUBUNIT (BETA-ADAPTIN 3A) (AP-3 COMPLEX BETA-3A SUBUNIT) (BETA-3A-ADAPTIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.225994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.184481446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP3M1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.162756\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 3 MU 1 SUBUNIT (MU-ADAPTIN 3A) (AP-3 ADAPTER COMPLEX MU3A SUBUNIT). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.732966\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.222051227\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AP3M2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.183942\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADAPTER-RELATED PROTEIN COMPLEX 3 MU 2 SUBUNIT (CLATHRIN COAT ASSEMBLY PROTEIN AP47 HOMOLOG 2) (CLATHRIN COAT ASSOCIATED PROTEIN AP47 HOMOLOG 2) (GOLGI ADAPTOR AP-1 47 KDA PROTEIN HOMOLOG 2) (HA1 47 KDA SUBUNIT HOMOLOG 2) (CLATHRIN ASSEMBLY PROTEIN ASSEMB\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.828397\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.22204571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APBA1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.16418\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2560\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 1 (NEURON- SPECIFIC X11 PROTEIN) (NEURONAL MUNC18-1-INTERACTING PROTEIN 1) (MINT-1) (ADAPTER PROTEIN X11ALPHA). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.766097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.214307066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APEX1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0811054\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2193\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE (EC 4.2.99.18) (AP ENDONUCLEASE 1) (APEX NUCLEASE) (APEN) (REF-1 PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.358823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.226031776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APEX2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0730689\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1655\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
APURINIC/APYRIMIDINIC ENDONUCLEASE 2; APURINIC/APYRIMIDINIC ENDONUCLEASE-LIKE 2; APEX NUCLEASE-LIKE 2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.305877\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.238883277\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
API5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0646874\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
APOPTOSIS INHIBITOR 5; FIBROBLAST GROWTH FACTOR 2-INTERACTING FACTOR 2; API5-LIKE 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.236716068\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APIP\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.184877\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2408\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.845209\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.218735248\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APOA1BP\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.180926\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2284\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
APOLIPOPROTEIN A-I BINDING PROTEIN; APOA-I BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.813521\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.222398684\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APOB\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0307397\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1387\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
APOLIPOPROTEIN B-100 PRECURSOR (APO B-100) [CONTAINS: APOLIPOPROTEIN B-48 (APO B-48)]. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.125741\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.244468391\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
APPBP1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0719023\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2597\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 1; AMYLOID PROTEIN-BINDING PROTEIN 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.337743\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.212890571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AQP1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0800859\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2839\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AQUAPORIN-CHIP (WATER CHANNEL PROTEIN FOR RED BLOOD CELLS AND KIDNEY PROXIMAL TUBULE) (AQUAPORIN 1) (AQP-1) (URINE WATER CHANNEL). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.415411\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.192787143\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AQP2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0608484\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2841\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AQUAPORIN-CD (AQP-CD) (WATER CHANNEL PROTEIN FOR RENAL COLLECTING DUCT) (ADH WATER CHANNEL) (AQUAPORIN 2) (COLLECTING DUCT WATER CHANNEL PROTEIN) (WCH-CD). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.315691\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.192746705\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AQP4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0599642\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2843\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AQUAPORIN 4 (WCH4) (MERCURIAL-INSENSITIVE WATER CHANNEL) (MIWC). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.311107\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.192744618\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AQP5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0604602\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2842\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AQUAPORIN 5. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.313678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.192746064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
AQR\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0339667\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1259\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.137332\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.247332741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARAF\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.218717\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2956\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
A-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE (EC 2.7.1.-) (A-RAF-1) (PROTO-ONCOGENE PKS). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48145\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.147637112\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARCN1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.293026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3017\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
COATOMER DELTA SUBUNIT (DELTA-COAT PROTEIN) (DELTA-COP) (ARCHAIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.41388\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.121392116\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARD1A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.304267\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1291\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
N-TERMINAL ACETYLTRANSFERASE COMPLEX ARD1 SUBUNIT HOMOLOG (EC 2.3.1.-). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.245906104\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARD1B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.269894\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1319\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.245644022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARF1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.384939\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
486\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.40333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.274303977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARF3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.224714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
481\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.819215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.274304059\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARF4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.106754\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
488\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR 4. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.389182\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.274303539\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARFGAP1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.145697\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2733\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR GTPASE ACTIVATING PROTEIN 1 (ADP-RIBOSYLATION FACTOR 1 GTPASE ACTIVATING PROTEIN) (ARF1 GAP) (ARF1-DIRECTED GTPASE- ACTIVATING PROTEIN) (GAP PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.709572\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.205330819\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARFGAP3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0344618\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
491\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR GTPASE-ACTIVATING PROTEIN 3 (ARF GAP 3). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.125634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.274303135\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARFGEF1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0337842\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE-EXCHANGE PROTEIN 1 (BREFELDIN A-INHIBITED GEP 1) (P200 ARF-GEP1) (P200 ARF GUANINE NUCLEOTIDE EXCHANGE FACTOR). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.242777582\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARFGEF2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.036822\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE-EXCHANGE PROTEIN 2 (BREFELDIN A-INHIBITED GEP 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.15167\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.242777082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARG1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.222245\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARGINASE 1 (EC 3.5.3.1) (LIVER-TYPE ARGINASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.945747\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.234994137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARG2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.18522\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"ARGINASE II, MITOCHONDRIAL PRECURSOR (EC 3.5.3.1) (NON-HEPATIC ARGINASE) (KIDNEY-TYPE ARGINASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.787708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.235137894\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGAP1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.119625\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RHO-GTPASE-ACTIVATING PROTEIN 1 (GTPASE-ACTIVATING PROTEIN RHOOGAP) (RHO-RELATED SMALL GTPASE PROTEIN ACTIVATOR) (CDC42 GTPASE-ACTIVATING PROTEIN) (P50-RHOGAP). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.460314\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.259876954\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/